Prepared by R.R. Donnelley Financial -- Form 8-K dated August 7, 2002
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of
earliest event reported) August 7, 2002
Targeted Genetics Corporation
(Exact name of registrant as specified in charter)
| Washington (State or other
jurisdiction of incorporation) |
|
0-23930 (Commission File Number) |
|
91-1549568 (IRS
Employer Identification No.) |
| 1100 Olive Way, Suite 100, Seattle, Washington (Address of principal executive offices) |
|
98101 (Zip
Code) |
Registrant’s telephone number, including area code (206) 623-7612
Not Applicable
(Former name or former address, if changed since last report)
Item 5. Other Events.
On August 7, 2002, Targeted Genetics Corporation announced that it is restructuring its operations to reduce expenses and concentrate its
resources on key product development programs and continuing business development activities. The text of the press release is set forth in Exhibit 99.1 attached to this release and incorporated herein by this reference.
Item 7. Exhibits.
(a) Financial statements of business acquired.
Not applicable.
(b) Pro forma financial information.
Not applicable.
(c) Exhibits.
| Exhibit No.
|
|
Description
|
| 99.1 |
|
Press Release dated August 7, 2002 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| TARGETED GENETICS CORPORATION |
| |
| By: |
|
/s/ TODD E.
SIMPSON
|
| |
|
Todd E. Simpson Vice
President, Finance and Administration and Chief Financial Officer, Secretary and Treasurer (Principal Financial and Accounting Officer) |
Date: August 8, 2002
3
EXHIBIT INDEX
| Exhibit No.
|
|
Description
|
| 99.1 |
|
Press Release dated August 7, 2002 |
4